Clinical trials
Phase 1 Multiple Sclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
193 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 5 |
| 2008 | 6 |
| 2009 | 7 |
| 2010 | 10 |
| 2011 | 5 |
| 2012 | 8 |
| 2013 | 6 |
| 2014 | 6 |
| 2015 | 11 |
| 2016 | 8 |
| 2017 | 6 |
| 2018 | 8 |
| 2019 | 12 |
| 2020 | 9 |
| 2021 | 14 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 15 |
| 2025 | 14 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 96 |
| Recruiting | 28 |
| Terminated | 20 |
| Unknown status | 16 |
| Not yet recruiting | 13 |
| Active, not recruiting | 10 |
| Withdrawn | 6 |
| Suspended | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 11 |
| GlaxoSmithKline | 7 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 6 |
| Contineum Therapeutics | 4 |
| Hoffmann-La Roche | 4 |
| Oregon Health and Science University | 4 |
| Sanofi | 4 |
| Daishi Tian | 3 |
| Institute for Neurodegenerative Disorders | 3 |
| Kessler Foundation | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 193 |
| Multiple Sclerosis, Chronic Progressive | 24 |
| Multiple Sclerosis, Relapsing-Remitting | 24 |
| Autoimmune Diseases | 13 |
| Myasthenia Gravis | 13 |
| Neuromyelitis Optica | 13 |
| Autoimmune Diseases of the Nervous System | 7 |
| Demyelinating Diseases | 7 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 7 |
| Lupus Erythematosus, Systemic | 6 |
Trials
Showing 51 to 75 of 193. Each trial links to its page on Pharma Observatory.
93 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.